4//SEC Filing
Trius Therapeutics Inc 4
Accession 0001209191-13-031713
CIK 0001356857operating
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 7:57 PM ET
Size
5.6 KB
Accession
0001209191-13-031713
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-06-11$8.94/sh−1,000$8,940→ 180,860 total(indirect: By Trust)
Holdings
- 2,151
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
- [F2]Includes 369 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/13.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001356857
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 7:57 PM ET
- Size
- 5.6 KB